BDBM332407 US10196353, Example 43::US11299457, Example 43

SMILES CC(C)(O)C(C)(C)n1ccc2c(C#N)c(ccc12)C#N

InChI Key InChIKey=VRUCIOQGHMDWET-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 332407   

TargetProgesterone receptor(Human)
Glaxosmithkline

US Patent
LigandPNGBDBM332407(US10196353, Example 43 | US11299457, Example 43)
Affinity DataIC50: 631nMAssay Description:Compounds are added to the 384 well black low-volume plates to a final volume of 0.1 μL. DTT and DMSO are added to the chilled assay buffer just...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/14/2019
Entry Details
Go to US Patent

TargetAndrogen receptor(Human)
Glaxosmithkline Intellectual Property (No. 2)

US Patent
LigandPNGBDBM332407(US10196353, Example 43 | US11299457, Example 43)
Affinity DataIC50: 631nMAssay Description:The androgen receptor fluorescence polarization assay is used to investigate the interaction of the compounds with the androgen receptor.Compounds ar...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/24/2022
Entry Details
Go to US Patent